AZF2 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to Antibodies

Antibodies, also known as immunoglobulins, are proteins produced by the immune system to recognize and bind to specific antigens. They are crucial components of the adaptive immune response and are used extensively in medical research and diagnostics.

Structure and Function of Antibodies

Antibodies are composed of four polypeptide chains: two heavy chains and two light chains, arranged in a Y shape. The variable domains of these chains provide specificity for antigen binding, while the constant domains determine the antibody's class and effector functions .

Types of Antibody Fragments

Antibodies can be fragmented into smaller pieces, such as F(ab) and F(ab')2 fragments, which retain antigen-binding capabilities but lack the Fc region. These fragments are useful in reducing background staining in immunohistochemistry and other applications .

Broadly Reacting Antibodies

Recent research has focused on identifying broadly reacting antibodies that can target multiple pathogens. For example, Vanderbilt researchers have isolated antibodies that can recognize multiple viruses, including HIV and SARS-CoV-2 .

Synthetic Antibodies

Synthetic antibodies engineered for broadened specificity have shown enhanced anti-tumor properties. For instance, a synthetic anti-Frizzled antibody was developed to target multiple Frizzled receptors involved in cancer progression .

Data Table: Types of Antibody Fragments

Fragment TypeDescriptionApplication
F(ab)Monovalent, lacks Fc regionReduces background staining in immunohistochemistry
F(ab')2Bivalent, retains some hinge regionUsed in applications requiring bivalent binding

References:

- Abcam. (2021). Immunoglobulin F(ab) and F(ab')2 fragments.
- Vanderbilt University Medical Center. (2024). VUMC method tracks down rare, broadly reacting antibodies: study.
- PMC. (2022). Design, synthesis, and biological evaluation of triazole-pyrimidine-methylbenzonitrile derivatives as dual A2A/A2B adenosine receptor antagonists.
- Jack Westin. (n.d.). Structure Of Antibody Molecule - Immune System - MCAT Content.
- PubMed. (2024). Combining Anti-Mitochondrial Antibodies, Anti-Histone, and PLA2...
- PMC. (2018). A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties.

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
AZF2 antibody; ZF2 antibody; At3g19580 antibody; MMB12.27 antibody; MMB12.4Zinc finger protein AZF2 antibody; Zinc-finger protein 2 antibody
Target Names
AZF2
Uniprot No.

Target Background

Function
AZF2 is a transcriptional repressor that inhibits plant growth under abiotic stress. It represses the expression of genes involved in osmotic stress, abscisic acid (ABA) response, and auxin signaling by binding to their promoter regions. Specifically, it negatively regulates ABA signaling during seed germination and is likely involved in early jasmonate (JA) signaling. AZF2 may regulate the expression of the JA biosynthesis gene *LOX3* and control *TIFY10A/JAZ1*, a key repressor in the JA signaling cascade. Additionally, AZF2 may positively regulate leaf senescence. Furthermore, AZF2 has been shown to suppress the growth deficiency of yeast *snf4* mutants on non-fermentable carbon sources.
Gene References Into Functions
PMID: 28184497, Transcript regulation studies of *AtbZIP9* and *AtAFZ2* during germination support AZF2's role in transcriptional regulation of *AtTrxo1*. Transient overexpression of *AtbZIP9* and *AtAZF2* in *Nicotiana benthamiana* leaves showed that *AtbZIP9* activates, while *AtAZF2* represses, *AtTrxo1* promoter-driven reporter expression., .
PMID: 22709441, AZF2 functions as a positive regulator of leaf senescence., .
PMID: 21852415, AZF1 and AZF2 act as transcriptional repressors, inhibiting plant growth under abiotic stress., .
PMID: 20619483, AZF2 acts as a negative regulator of ABA signaling in seeds., .
Database Links

KEGG: ath:AT3G19580

STRING: 3702.AT3G19580.1

UniGene: At.23023

Subcellular Location
Nucleus.
Tissue Specificity
Expressed in roots, radicles, cotyledons, hypocotyls, leaf veins, stems, sepals, petals, stamens, placenta, funiculi and maturated seeds.

Q&A

What is AZF2 and why are antibodies against it important for plant research?

AZF2 (Zinc finger protein 2) is a nuclear-localized transcriptional repressor belonging to the C2H2-type zinc finger protein family in plants. It plays a critical role in transcriptional regulation mechanisms, particularly in Arabidopsis thaliana and related species .
AZF2 antibodies are essential tools for:

  • Studying transcriptional repression mechanisms in plants

  • Investigating plant stress responses where zinc finger proteins often play regulatory roles

  • Examining protein-DNA interactions in gene expression control

  • Validating gene knockout or overexpression studies
    Methodologically, when designing experiments using AZF2 antibodies, researchers should consider the nuclear localization of the protein and ensure appropriate nuclear extraction protocols are employed for optimal results.

What applications are most effective for AZF2 antibody usage in plant science?

Based on validated research protocols, AZF2 antibodies are primarily effective in:

  • Western Blotting (WB): Typically used at 1:1000-1:2000 dilution ranges

  • ELISA: For quantitative detection of AZF2 protein levels
    For Western blot applications, researchers should note:

  • Expected molecular weight of approximately 30 kDa for AZF2

  • Optimal blocking with 5% skim milk

  • Recommended secondary antibodies include HRP-conjugated anti-rabbit IgG
    Unlike some antibodies with broader application ranges, current data does not strongly support using AZF2 antibodies for immunohistochemistry or immunoprecipitation without additional validation.

What species reactivity should be expected when using commercial AZF2 antibodies?

Current AZF2 antibodies show confirmed reactivity with:

SpeciesHomology to ImmunogenValidated Applications
Arabidopsis thalianaReference sequenceWB, ELISA
Brassica napus80-99% homologyWB (predicted)
Brassica rapa80-99% homologyWB (predicted)
Before using in other plant species, researchers should perform sequence alignment analysis of the immunogen region (typically the N-terminal section of AZF2) to predict potential cross-reactivity . For species with lower homology scores, additional validation steps are strongly recommended.

What are the optimal storage and handling conditions for maintaining AZF2 antibody activity?

For maximum stability and performance of AZF2 antibodies:

  • Long-term storage: -20°C to -70°C for 12 months from receipt date

  • Medium-term storage: -20°C to -70°C for 6 months under sterile conditions after reconstitution

  • Short-term storage: 2-8°C for up to 1 month under sterile conditions after reconstitution

  • Shipping conditions: Typically shipped at 4°C and should be stored immediately upon receipt
    For lyophilized antibodies:

  • Centrifuge vial briefly before opening to prevent loss of material

  • Reconstitute with the recommended volume of sterile water (typically 150 μl for standard packaging)

  • Avoid repeated freeze-thaw cycles by making small aliquots after reconstitution

How can researchers validate the specificity of AZF2 antibodies for their experimental systems?

Comprehensive validation requires multiple approaches:

  • Positive/Negative Controls:

    • Use recombinant AZF2 protein as a positive control (provided with some antibodies)

    • Use pre-immune serum as a negative control

    • Include AZF2 knockout/knockdown samples when available

  • Immunogen Competition Assay:

    • Pre-incubate the antibody with excess immunogenic peptide

    • Compare detection with and without peptide competition

    • Specific signals should be significantly reduced in competition conditions

  • Molecular Weight Verification:

    • Confirm detection at expected 30 kDa range

    • Compare with calculated molecular weight based on amino acid composition

    • Note that post-translational modifications might cause migration differences

  • Cross-Validation with Multiple Antibodies:

    • When possible, use antibodies targeting different epitopes of AZF2

    • Converging results from different antibodies strengthen specificity claims
      This multi-faceted approach minimizes risks of non-specific binding and misinterpretation, which is particularly important given the structural similarity between different zinc finger proteins.

What considerations should researchers make when selecting between different AZF2 antibody preparations?

When choosing between different AZF2 antibodies, consider:

  • Epitope Location:

    • N-terminal targeting antibodies (e.g., those using 15 aa peptides from N-terminus)

    • Full-length protein immunogens

    • Different epitopes may affect detection of splice variants or processed forms

  • Antibody Format:

    • Serum preparations versus affinity-purified antibodies

    • Peptide affinity-purified versus protein A/G purified

    • Higher purification typically reduces background but may reduce sensitivity

  • Validation Depth:

    • Extent of validation data available from the manufacturer

    • Peer-reviewed publications using the specific antibody clone

    • Available positive control materials (some suppliers provide recombinant proteins)

  • Cross-Reactivity Analysis:

    Antibody TypeAdvantagesLimitations
    PolyclonalHigher sensitivity, multiple epitopesBatch-to-batch variation
    Monoclonal (if available)Consistency, higher specificityPotentially lower sensitivity

When possible, researchers should test multiple antibody preparations to determine which performs optimally in their specific experimental system.

What are the most effective approaches for troubleshooting weak or non-specific signals when using AZF2 antibodies?

When encountering issues with AZF2 antibody performance:

  • For Weak Signals:

    • Increase antibody concentration (try 1:500 dilution if 1:1000 is insufficient)

    • Extend primary antibody incubation time (overnight at 4°C)

    • Optimize protein extraction specifically for nuclear proteins

    • Use enhanced chemiluminescence detection systems with longer exposure times

    • Consider using a protein enrichment step before detection

  • For Non-Specific Signals:

    • Implement more stringent blocking (try 5-10% BSA instead of milk)

    • Increase washing duration and frequency (5-6 washes of 10 minutes each)

    • Use higher salt concentration in wash buffers (up to 500 mM NaCl)

    • Consider adding 0.1-0.5% Triton X-100 to wash buffers

    • Test different secondary antibodies with lower background

  • For Inconsistent Results:

    • Standardize protein extraction methodology

    • Control for protein degradation by adding protease inhibitors

    • Consider how growth conditions affect AZF2 expression levels

    • Document detailed protocols to ensure consistency
      Implementing a systematic approach to troubleshooting is essential, modifying one variable at a time and comparing results with appropriate controls.

How can researchers optimize experimental design for studying AZF2 protein interactions using antibody-based approaches?

For investigating AZF2 interactions with DNA, proteins, or other cellular components:

  • Co-Immunoprecipitation (Co-IP) Optimization:

    • Select antibodies validated for immunoprecipitation applications

    • Use mild lysis conditions to preserve protein-protein interactions

    • Cross-link antibodies to solid support to avoid heavy chain interference

    • Include appropriate controls (IgG, pre-immune serum)

    • Confirm results using reciprocal Co-IP when possible

  • Chromatin Immunoprecipitation (ChIP) Approaches:

    • Optimize fixation time for zinc finger proteins (typically 10-15 minutes)

    • Use sonication conditions that produce 200-500 bp DNA fragments

    • Include input controls and non-specific antibody controls

    • Verify enrichment using known target genes or sequences

    • Consider sequential ChIP for complex transcriptional complexes

  • Proximity Ligation Assay (PLA) Considerations:

    • Combine AZF2 antibody with antibodies against suspected interaction partners

    • Optimize fixation and permeabilization for nuclear proteins

    • Include appropriate negative controls (single antibody, non-related protein)

    • Quantify PLA signals using appropriate image analysis software
      Each of these approaches requires method-specific optimization, but they can provide complementary data about AZF2's role in transcriptional regulation mechanisms .

What are the latest methodological advances in antibody technology that could enhance AZF2 research?

Recent technological developments applicable to AZF2 research include:

  • Cell-Free Antibody Fragment Synthesis:

    • Production of Fv and Fab fragments with high yield (>1 mg/ml)

    • Critical role of disulfide isomerase (DsbC) concentration for soluble antibody fragments

    • Potential for site-specific labeling using p-azido-L-phenylalanine (AzF)

    • Application for structural analysis of antibody-antigen complexes

  • Computational Antibody Design Approaches:

    • Biophysics-informed models to predict and generate antibody variants

    • Identification of different binding modes for closely related ligands

    • Design of antibodies with customized specificity profiles

    • Mitigation of experimental artifacts and biases in selection experiments

  • NGS-Based Antibody Analysis:

    • Analysis of millions of antibody sequences with automated annotation

    • Clustering and filtering according to specific requirements

    • Visualization of sequence diversity and region frequency

    • Deep understanding of antibody sequence-function relationships
      These advanced methods could significantly enhance specificity, sensitivity, and multiplexing capabilities in AZF2 research, particularly for investigating its role in transcriptional networks.

How does AZF2 research intersect with broader studies of zinc finger proteins and transcriptional regulation?

AZF2 research should be contextualized within the broader zinc finger protein field:

  • Structural Considerations:

    • C2H2 zinc finger domains common to many transcriptional regulators

    • Potential for targeting with small molecules similar to thalidomide analogs

    • Structural basis for protein-DNA interactions

  • Functional Parallels with Other Systems:

    • Comparison with human zinc finger proteins like ZNF274

    • Shared mechanisms of transcriptional repression across species

    • Evolutionary conservation of zinc finger domain structure and function

  • Methodological Cross-Application:

    • Lessons from antibody validation in other zinc finger systems

    • Adaptation of techniques from human ZF protein research

    • Potential for heterologous expression systems for structural studies
      Understanding these intersections allows researchers to:

  • Apply lessons from other zinc finger protein research

  • Develop hypotheses based on conserved mechanisms

  • Adapt successful methodological approaches from related fields

  • Position AZF2 findings within broader transcriptional regulation paradigms This contextual awareness is particularly valuable given the diverse roles of zinc finger proteins across different biological systems and their importance in transcriptional regulation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.